57
Views
8
CrossRef citations to date
0
Altmetric
Review

Targeting mulitple dyslipidemias with fixed combinations – focus on extended release niacin and simvastatin

, , &
Pages 1001-1009 | Published online: 10 Oct 2008

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (3)

Christopher P. F. Marinangeli & Peter J. H. Jones. (2010) Functional food ingredients as adjunctive therapies to pharmacotherapy for treating disorders of metabolic syndrome. Annals of Medicine 42:5, pages 317-333.
Read now
Kai-Hang Yiu, Bernard MY Cheung & Hung-Fat Tse. (2010) A new paradigm for managing dyslipidemia with combination therapy: laropiprant + niacin + simvastatin. Expert Opinion on Investigational Drugs 19:3, pages 437-449.
Read now

Articles from other publishers (5)

Eman Alefishat, Anan S. Jarab, Walid Al-Qerem & Lina Abu-Zaytoun. (2021) Factors Associated with Medication Non-Adherence in Patients with Dyslipidemia. Healthcare 9:7, pages 813.
Crossref
Ye Sun, Yanqing Tang, Xufeng Hou, Hesong Wang, Liuying Huang, Junjie Wen, Hongxin Niu, Weisen Zeng & Yang Bai. (2020) Novel Lactobacillus reuteri HI120 Affects Lipid Metabolism in C57BL/6 Obese Mice. Frontiers in Veterinary Science 7.
Crossref
Saengryeol Park, So-Youn Park, Gapjin Oh & In-Hwan Oh. (2019) Latent Profiles Based on Light Physical Activity, Sedentary Behavior, Perceived Body Shape, and Body Mass Index in Patients with Dyslipidemia Influence Their Quality of Life. International Journal of Environmental Research and Public Health 16:20, pages 4034.
Crossref
Miroslav Zeman, Marek Vecka, František Perlík, Barbora Staňková, Robert Hromádka, Eva Tvrzická, Jakub Širc, Jakub Hrib & Aleš Žák. (2016) Pleiotropic effects of niacin: Current possibilities for its clinical use. Acta Pharmaceutica 66:4, pages 449-469.
Crossref
Dustin L. Cooper, Derek E. Murrell, David S. Roane & Sam Harirforoosh. (2015) Effects of formulation design on niacin therapeutics: mechanism of action, metabolism, and drug delivery. International Journal of Pharmaceutics 490:1-2, pages 55-64.
Crossref